Toronto Dominion Bank
WST icon

Toronto Dominion Bank’s West Pharmaceutical WST Stock Holding History

Toronto Dominion Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$125K – 2437
2025
Q4 		$125K Buy
+500
New +$137K ﹤0.01% 1532

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Toronto Dominion Bank's WST Position: Q2 2026 in Review

Toronto Dominion Bank increased its West Pharmaceutical (WST) stake by 1.9% in Q2 2026, buying an estimated $123K and bringing the position to 21,624 shares worth $7.76M. The position accounts for 0.01% of the portfolio, ranked #777.

Toronto Dominion Bank first reported a position in WST in Q1 2016 and has held it in 36 quarters since. The position peaked at $23.3M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Toronto Dominion Bank held 21,624 shares of West Pharmaceutical worth $7.76M as of Q2 2026.
  • Toronto Dominion Bank bought 403 West Pharmaceutical shares in Q2 2026, an estimated $123K.
  • West Pharmaceutical made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #777 holding.
  • Toronto Dominion Bank first reported a position in West Pharmaceutical in Q1 2016 and has held it in 36 quarters since.
  • Toronto Dominion Bank's West Pharmaceutical position peaked at $23.3M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.